IL33 and neoplasm: Ablation of IL-33 reprograms Tregs to upregulate IFNγ expression and maintain Foxp3 expression, consistent with a “fragile” phenotype, which exhibits reduced suppressive function in vivo, thereby accelerating tumor regression [159, 160].